IP Library Granted Patent US 9,708,652
Granted Patent B2
US 9,708,652 · App. 13/859,034 · Granted Jul 18, 2017

Methods and compositions for generating and amplifying DNA libraries for sensitive detection and analysis of DNA methylation

Inventors: Vladimir L. Makarov (Ann Arbor, MI); Emmanuel Kamberov (Ann Arbor, MI); Tong Sun (Novi, MI); Jonathan H. Pinter (Ypsilanti, MI); Brendan J. Tarrier (Whitmore Lake, MI); Eric E. Bruening (Chelsea, MI); Takao Kurihara (Ann Arbor, MI); Tim Tesmer (Whittaker, MI); Joseph M'Mwirichia (Ypsilanti, MI)
Assignee: RUBICON GENOMICS, INC.
C12Q1/6869C12N15/1072C12Q1/6827C12Q1/6855
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,708,652
App. No.
13/859,034
Granted
Jul 18, 2017
Kind
B2
Abstract

The present invention regards a variety of methods and compositions for obtaining epigenetic information, such as DNA methylation patterns, through the preparation, amplification and analysis of Methylome libraries. In particular, the method employs preparation of a DNA molecule by digesting the DNA molecule with at least one methylation-sensitive restriction enzyme; incorporating a nucleic acid molecule into at least some of the digested DNA molecules by either (1) incorporating at least one primer from a plurality of primers that have a 5′ constant sequence and a 3′ variable sequence, wherein the primers are substantially non-self-complementary and substantially non-complementary to other primers in the plurality; or (2) incorporating an oligonucleotide having an inverted repeat and a loop under conditions wherein the oligonucleotide becomes blunt-end ligated to one strand of the digested DNA molecule, followed by polymerization from a 3′ hydroxyl group present in a nick in the oligonucleotide-linked molecule; and amplifying one or more of the DNA molecules.

Claims (39)

1. A method of preparing a DNA molecule, comprising the steps of:

(1) providing a DNA molecule;

(2) providing an oligonucleotide-linked DNA molecule in a single incubation, said single incubation comprising:

(a) modifying the ends of the DNA molecule to provide attachable ends;

(b) ligating a first oligonucleotide comprising a known sequence and a nonblocked 3, end to an end of the DNA molecule to produce an oligonucleotide-linked molecule, wherein the 5′ end of the DNA molecule is attached to the nonblocked 3, end of the first oligonucleotide, leaving a nick site between a juxtaposed 3′ end of the DNA molecule and a 5′ end of the first oligonucleotide; and

(c) extending the juxtaposed 3, end of the DNA molecule from the nick site by polymerization;

(3) digesting the oligonucleotide-linked molecule with a mixture of methylation-sensitive restriction enzymes that do not cleave within the first oligonucleotide of the oligonucleotide-linked molecule; and

(4) amplifying the digested oligonucleotide-linked molecule with a primer complementary to at least a portion of the known sequence of the first oligonucleotide to produce amplified oligonucleotide-linked molecules.

2. The method of claim 1 , further comprising the step of determining at least part of the sequence of the amplified oligonucleotide-linked molecules.

3. The method of claim 1 , wherein the DNA molecule is from a body fluid or a tissue.

4. The method of claim 3 , wherein the body fluid comprises blood, serum, urine, cerebrospinal fluid, nipple aspirate, sweat, or saliva.

5. The method of claim 3 , wherein the tissue comprises biopsy, surgical sample, or cheek scrapings.

6. The method of claim 1 , wherein digestion of the oligonucleotide-linked molecule with the mixture of methylation-sensitive restriction enzymes occurs during step (2).

7. The method of claim 1 , wherein the oligonucleotide-linked molecule comprises a non-replicable region in the first oligonucleotide portion.

8. The method of claim 7 , wherein the non-replicable region is generated during step (2).

9. The method of claim 7 , wherein the non-replicable region comprises at least one abasic site.

10. The method of claim 9 , wherein the at least one abasic site is generated from at least one deoxyuridine located within the non-replicable region of the first oligonucleotide.

11. The method of claim 7 , wherein the 3′ end of the DNA molecule is extended from the nick site up to the non-replicable region of the first oligonucleotide portion.

12. The method of claim 9 , wherein the amplifying step comprises a first heating step to fragment the at least one abasic region of the oligonucleotide-linked molecule.

13. The method of claim 1 , further comprising a step wherein sodium bisulfite is provided to said oligonucleotide-linked molecule, wherein any unmethylated cytosines in said oligonucleotide-linked molecule are converted to uracil, thereby producing a bisulfite-converted molecule.

14. The method of claim 1 , wherein the first oligonucleotide is further defined as comprising a 3′ stem region, wherein said 3′ stem region does not comprise guanine and wherein all cytosines are methylated.

15. The method of claim 1 , further comprising a step of enriching for oligonucleotide-linked molecules comprising CpG-rich regions.

16. The method of claim 1 , further comprising a step of comparing at least part of a sequence of the amplified oligonucleotide-linked molecules with a control DNA molecule that was not subjected to the digesting step.

17. The method of claim 6 , wherein the single incubation comprises the DNA molecule, a DNA polymerase, a DNA ligase, the first oligonucleotide, and the mixture of methylation-sensitive restriction enzymes.

18. The method of claim 1 , wherein the first oligonucleotide is a stem-loop adaptor having an inverted repeat and a loop.

19. The method of claim 18 , wherein the inverted repeat comprises a 5′ stem region and a 3′ stem region that is complementary to the 5′ stem region.

20. The method of claim 19 , wherein the first oligonucleotide comprises a non-replicable base in the loop region.

21. The method of claim 20 , wherein the first oligonucleotide further comprises a non-replicable base within the 5′ stem region.

22. The method of claim 1 , wherein the first oligonucleotide does not contain a loop.

23. The method of claim 1 , wherein the DNA molecule has been fragmented mechanically or chemically.

24. The method of claim 23 , wherein the DNA molecule has been fragmented by sonication.

25. The method of claim 1 , wherein the DNA molecule has been fragmented by enzymatic fragmentation.

26. The method of claim 1 , wherein the enzymatic fragmentation is by at least one site-specific restriction endonuclease.

27. The method of claim 1 , wherein the enzymatic fragmentation is by a random endonuclease.

28. The method of claim 1 , wherein the DNA molecule has been fragmented in vivo.

29. The method of claim 28 , wherein the DNA molecule is the product of apoptosis-induced degradation.

30. The method of claim 1 , wherein the extending of step (2)(d) comprises nick translation polymerization.

31. The method of claim 1 , wherein the extending of step (2)(d) comprises strand displacement polymerization.

32. The method of claim 1 , wherein the incubation of step (2) further comprises repairing nicks and/or gaps within the DNA molecule.

Assignments (2)
MERGER Recorded Sep 19, 2017
From: RUBICON GENOMICS, INC.
To: TAKARA BIO USA, INC.
Reel/Frame 043631/0549 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 6, 2016
From: MAKAROV, VLADIMIR L.; SUN, TONG; KAMBEROV, EMMANUEL; BRUENING, ERIC E.; PINTER, JONATHON H.; TARRIER, BRENDAN J.; KURIHARA, TAKAO; TESMER, TIM; M'MWIRICHIA, JOSEPH
To: RUBICON GENOMICS, INC.
Reel/Frame 040532/0555 →
Continuity (3)
Continuation 11071864 · Mar 3, 2005
Provisional Application 60551941 · Mar 8, 2004
Related Publication 20130309668A1 · Nov 21, 2013